PMID- 24682924 OWN - NLM STAT- MEDLINE DCOM- 20150528 LR - 20211021 IS - 1559-1166 (Electronic) IS - 0895-8696 (Linking) VI - 54 IP - 2 DP - 2014 TI - Induction of matrix metalloproteinase-3 (MMP-3) expression in the microglia by lipopolysaccharide (LPS) via upregulation of glycoprotein nonmetastatic melanoma B (GPNMB) expression. PG - 234-42 LID - 10.1007/s12031-014-0280-0 [doi] AB - Substantial evidence suggests that inflammation is an important contributor to many neurodegenerative disorders. Activated microglial cells play an important role in releasing pro-inflammatory factors, including tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) for inducing inflammation. Recently, some reports have suggested that glycoprotein nonmetastatic melanoma B (GPNMB) is highly expressed in microglia after LPS treatment. However, the role of GPNMB in activated microglia is not clearly understood. In this study, we used RT-PCR and Western blotting to detect GPNMB and matrix metalloproteinase-3 (MMP-3) expressions in activated microglia. GPNMB small interfering RNA (siRNA) or MMP-3 inhibitor was applied on microglial BV2 cells, and ELISA was performed to measure the expressions of TNF-alpha and IL-1beta in BV2 cells. Levels of iNOS and NO in BV2 cells were also determined. We found that the levels of GPNMB and MMP-3 were significantly increased in BV2 cells after LPS treatment. Moreover, we found that GPNMB significantly upregulated the expression of MMP-3 in BV2 cells, and high expression of MMP-3 was dependent on the level of GPNMB. Inhibition of GPNMB or MMP-3 expression by GPNMB siRNA or MMP-3 inhibitor dramatically suppressed the expressions of TNF-alpha, IL-1beta, iNOS, and NO in activated microglia. All of these results suggest that GPNMB is involved in the inflammatory responses of microglia. FAU - Shi, Fangyuan AU - Shi F AD - Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Science, Northwest University, Xi'an, 710069, China. FAU - Duan, Shuangyan AU - Duan S FAU - Cui, Jihong AU - Cui J FAU - Yan, Xingrong AU - Yan X FAU - Li, Hongmin AU - Li H FAU - Wang, Yingjuan AU - Wang Y FAU - Chen, Fulin AU - Chen F FAU - Zhang, Lihua AU - Zhang L FAU - Liu, Jun AU - Liu J FAU - Xie, Xin AU - Xie X LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140330 PL - United States TA - J Mol Neurosci JT - Journal of molecular neuroscience : MN JID - 9002991 RN - 0 (Eye Proteins) RN - 0 (Gpnmb protein, mouse) RN - 0 (Interleukin-1beta) RN - 0 (Lipopolysaccharides) RN - 0 (Membrane Glycoproteins) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - EC 3.4.24.17 (Mmp3 protein, mouse) SB - IM MH - Animals MH - Cell Line MH - Eye Proteins/genetics/*metabolism MH - Interleukin-1beta/genetics/metabolism MH - Lipopolysaccharides/pharmacology MH - Matrix Metalloproteinase 3/genetics/*metabolism MH - Membrane Glycoproteins/genetics/*metabolism MH - Mice MH - Microglia/drug effects/*metabolism MH - Nitric Oxide Synthase Type II/genetics/metabolism MH - Tumor Necrosis Factor-alpha/genetics/metabolism MH - *Up-Regulation EDAT- 2014/04/01 06:00 MHDA- 2015/05/29 06:00 CRDT- 2014/04/01 06:00 PHST- 2014/02/21 00:00 [received] PHST- 2014/03/03 00:00 [accepted] PHST- 2014/04/01 06:00 [entrez] PHST- 2014/04/01 06:00 [pubmed] PHST- 2015/05/29 06:00 [medline] AID - 10.1007/s12031-014-0280-0 [doi] PST - ppublish SO - J Mol Neurosci. 2014;54(2):234-42. doi: 10.1007/s12031-014-0280-0. Epub 2014 Mar 30.